ABCM - Abcam plc
After hours:
Chart Events
Price Crosses Moving Average
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 16.87 |
| Open | 16.68 |
| Bid | 16.14 x 800 |
| Ask | 16.14 x 800 |
| Day's Range | 16.01 - 16.99 |
| 52 Week Range | 12.48 - 18.38 |
| Volume | |
| Avg. Volume | 854,358 |
| Market Cap | 3.685B |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Mar 19, 2020 |
| 1y Target Est | 19.90 |
Fair Value
Related Research
PR NewswireABCAM PLC: Statement on calling an Extraordinary General Meeting
Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, notes that it has received a notice from Dr. Jonathan Milner seeking to require the Board of Directors to convene an Extraordinary General Meeting (the "EGM"). The Company is reviewing the notice with its legal advisors and will provide a further update in due course. Shareholders do not need to take any action at this time.
ZacksHow Much Upside is Left in Abcam PLC Sponsored ADR (ABCM)? Wall Street Analysts Think 27.55%
The mean of analysts' price targets for Abcam PLC Sponsored ADR (ABCM) points to a 27.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
PR NewswireABCAM PLC Result of Annual General Meeting
Abcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces the voting results from the Annual General Meeting (the "AGM") held today. A total of 196,862,506 shares representing 85.7% of Abcam's issued and outstanding voting capital (including withheld) were voted in connection with the meeting.
BloombergAbcam Founder Ramps Up Board Seat Push at $4 Billion Biotech
(Bloomberg) -- UK entrepreneur Jonathan Milner is ramping up pressure on Abcam Plc to give him a board seat, as he seeks to improve performance at the biotechnology supplier he started 25 years ago. Most Read from BloombergElon Musk Says He’s Stepping Down as Twitter’s CEOKen Griffin’s Hand-Picked Math Prodigy Runs Market-Making EmpireJamie Dimon Says US Needs to 'Finish' the Bank CrisisFlorida’s Money Man Threatens to Cut Ties With Bank of America, Wells FargoTurkey Markets Rally as Candidate W
BloombergAbcam Founder Pushes for Better Performance at Biotech
(Bloomberg) -- Abcam Plc founder Jonathan Milner is pushing for better performance at the biotechnology supplier he started 25 years ago.Most Read from BloombergJamie Dimon Says US Needs to 'Finish' the Bank CrisisTurkey Markets Rally as Candidate Withdraws Days Before VoteHedge Funds Drive Credit Suisse CDS Higher on Bets of a PayoutFamily Builds $900 Million Brazil Farming Empire After 935% GainSteve Schwarzman Holds Off Giving Money to DeSantis After Meeting HimThe British scientist and entre
PR NewswireAbcam, plc Business Update
Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following updates.
PR NewswireABCAM PLC Comments on Investor Engagement
Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, notes the Form 13D filed today by founder and former director Dr Jonathan Milner and related press reports.
- PR Newswire
ABCAM PLC: Upcoming Abcam Investor Events
Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the following investor events.
- PR Newswire
ABCAM PLC: Trading Update
Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following preliminary trading update for the quarter ending 31 March 2023.
PR NewswireAbcam, plc Publication of 2022 Annual Report and Accounts and Notice of Annual General Meeting
Abcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 20 March 2023 of its final results for the year ended 31 December 2022 on Form 20-F with the Securities and Exchange Commission, the Abcam plc Annual Report and Accounts 2022 (the "Annual Report") have been published today and are available on the Abcam plc website at corporate.abcam.com
- PR Newswire
ABCAM PLC: Final results for the year ended 31 December 2022
Abcam plc (Nasdaq: ABCM) ('Abcam', the 'Group' or the 'Company'), a global leader in the supply of life science research tools, today announces its results for the year ended 31 December 2022 (the 'period').
- PR Newswire
Abcam to Report Full Year Results on Monday, March 20, 2023
Abcam plc (Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, will report its results for the year ended 31 December 2022 at 7.00 a.m. ET on 20 March 2023.
American City Business JournalsA biotechnology product supplier is shuttering its office in Milpitas and cutting 30 workers
Abcam plans to shutter its Milpitas location about 17 months after it acquired BioVision, which operated there.
Insider Monkey10 Best Medical Stocks Under $20
In this article, we discuss 10 best medical stocks under $20. If you want to see more stocks in this selection, check out 5 Best Medical Stocks Under $20. The healthcare industry has undergone a significant restructuring in the wake of the COVID-19 pandemic. There were multiple new healthcare trends in 2022 that have a […]
- PR Newswire
Abcam plc: Update on AIM Delisting
Abcam plc, (AIM: ABC) and (NASDAQ: ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, today provides a further update with respect to the cancellation of admission of its Ordinary Shares to trading on AIM (the "AIM Delisting"), as originally announced on 17 October 2022.
GuruFocus.comIs Abcam the Perfect Nasdaq Stock?
A great 'pick and shovel' play within the biotechnology sector
- PR Newswire
ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting
Abcam plc (AIM: ABCM) (ABC: ABCM) (Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, today announces that the resolution put to its General Meeting held today for the cancellation of the admission of its Ordinary Shares to trading on AIM was passed.
Business WireNanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research
SEATTLE & CAMBRIDGE, United Kingdom, November 09, 2022--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Abcam (AIM: ABC; NASDAQ: ABCM), a global life science company working together with researchers to advance science and enable faster breakthroughs, today announced the expansion of their long-standing relationship with a new agreement to co-market Abcam antibodies for NanoString’s high-plex spatial multiomic s
PR NewswireABCAM PLC: Proposed resolution for cancellation of AIM listing
Abcam plc, (AIM: ABC) (Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, today announces:
Insider Monkey11 Cheap Healthcare Stocks To Invest In
In this article, we discuss the 11 cheap healthcare stocks to invest in. If you want to skip the detailed analysis of the healthcare industry, go directly to 5 Cheap Healthcare Stocks To Invest In. Healthcare is one of the biggest sectors in the world. According to a research report, the healthcare consumer market size was […]
- Thomson Reuters StreetEvents
Edited Transcript of ABCA.L earnings conference call or presentation 12-Sep-22 12:00pm GMT
Full Year 2022 Abcam PLC Earnings Call
- PR Newswire
ABCAM PLC: Interim results for the six-month period ended 30 June 2022
Abcam plc (NASDAQ: ABCM) (AIM: ABC) ('Abcam', the 'Group' or the 'Company'), a global leader in the supply of life science research tools, today announces its interim results for the six-month period ended 30 June 2022 (the 'period').
- PR Newswire
ABCAM PLC First Half Trading Update
Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update for the six-month period ending 30 June 2022. The Company will release its full results for the six-month period on 12 September 2022.
Simply Wall St.Great news for Abcam plc (LON:ABC): Insiders acquired stock in large numbers last year
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
- PR Newswire
Abcam: Appointment of Vice President of Investor Relations
Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations.